See What HealthDay Can Do For You
Contact Us

June 2010 Briefing - Cosmetic Surgery

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for June 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

S. aureus Infections a Greater Risk After Certain Procedures

THURSDAY, June 10 (HealthDay News) -- The frequency and type of invasive Staphylococcus aureus infections following surgeries vary according to the type of procedure, with cardiothoracic and neurosurgical procedures linked to the highest risks, according to research published in the July issue of Infection Control & Hospital Epidemiology.

Abstract
Full Text (subscription or payment may be required)

Triple Combination Cream Reduces Melasma Severity

TUESDAY, June 8 (HealthDay News) -- Although using daily triple combination (TC) cream for 12 weeks is safe and effective in reducing melasma severity enough for patients to reduce administration to twice per week, most patients relapse, requiring resumption of daily therapy, according to a study in the June issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Rural Residents Less Likely to Use Sunscreen

THURSDAY, June 3 (HealthDay News) -- Rural residents are less likely than urban residents to use sunscreen, but this may be explained by confounding factors such as differences in age and income, according to a study in the June issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.